The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis
Open accessAbstract
Objective : To assess treatment discontinuation rates with selective serotonin reuptake inhibitors compared with tricyclic antidepressants. Design : Meta-analysis of 62 randomised controlled trials. Subjects : 6029 patients with major unipolar depression. Main outcome measures : Pooled risk ratios for drop out rates with respect to all cases of discontinuation and those due to side effects and treatment failure. Results : The total discontinuation rate was 10% lower with selective serotonin reuptake inhibitors than with tricyclic antidepressants (risk ratio 0.90; 95% confidence interval 0.84 to 0.97) and the drop out rate due to side effects was 25% lower (risk ratio 0.75; 0.66 to 0.84). There was no significant difference between drug classes in the drop out rates for treatment failure. The risk ratios for drop out did not differ significantly between individual selective serotonin reuptake inhibitors. Conclusions : Selective serotonin reuptake inhibitors are better tolerated than tricyclic antidepressants as measured by total numbers of drop outs. The definite advantage to selective serotonin reuptake inhibitors is explained by fewer drop outs due to side effects. The overall difference, however, is comparatively small and may not be clinically relevant. Analyses of cost effectiveness should not overestimate the advantage to selective serotonin reuptake inhibitors. Key messages: Key messages In a meta-analysis of randomised, short term clinical trials selective serotonin reuptake inhibitors were associated with 10% fewer overall drop outs than tricyclic antidepressants (nine drop outs for every 10 with tricyclic agents) This difference was accounted for by a lower rate of drop out related to side effects of selective serotonin reuptake inhibitors (25% reduction; three drop outs for every four with tricyclic agents) This comparatively small difference in drop out rate is of uncertain importance clinically and when cost effectiveness is considered Further studies of the tolerability of selective serotonin reuptake inhibitors compared with that of tricyclic antidepressants are required over a longer period in the setting of clinical practice rather than clinical trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Kupper, L. L., Hosmer, D. W., & Lemeshow, S. (1990) · Journal of the American Statistical Association · doi:10.2307/2290035 · Cited by 7,599
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Statistical Methods in Medical Research
Lachenbruch, P. A. (1972) · Technometrics · doi:10.1080/00401706.1972.10488903 · Cited by 1,703
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Diet, Body Size, and Breast Cancer
Hunter, D. J., & Willett, W. C. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036096 · Cited by 489
Cigarette Smoking and Urinary Estrogens
MacMahon, B., Trichopoulos, D., Cole, P., & Brown, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071707 · Cited by 404
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
Gram, L. (1986) · Psychopharmacology · doi:10.1007/bf00172884 · Cited by 301
Clinically useful measures of effect in binary analyses of randomized trials
Sinclair, J. C., & Bracken, M. B. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90191-0 · Cited by 270
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder
COHN, J. B., COLLINS, G., ASHBROOK, E., & WERNICKE, J. F. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198910000-00006 · Cited by 257
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates
Montgomery, S. A., Henry, J., McDonald, G., Dinan, T., Lader, M., Hindmarch, I., Clare, A., & Nutt, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00008 · Cited by 254
Anderson, I. M., & Tomenson, B. M. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800407 · Cited by 250
Self-citationJick, S. S., Dean, A. D., & Jick, H. (1995) · BMJ · doi:10.1136/bmj.310.6974.215 · Cited by 249
Stark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239
Jönsson, B., & Bebbington, P. E. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.5.665 · Cited by 223
Pearce, J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.11.1314 · Cited by 202
Chouinard, G. (1985) · PubMed · Cited by 184
Cigarette Smoking and the Risk of Breast Cancer
Palmer, J. R., & Rosenberg, L. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036098 · Cited by 178
A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients
Dunbar, G. C., Cohn, J. B., Fabre, L. F., Feighner, J. P., Fieve, R. R., Mendels, J., & Shrivastava, R. K. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.3.394 · Cited by 175
Feighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 171
The compliance with antidepressants in general practice
Maddox, J. C., Levi, M., & Thompson, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800108 · Cited by 148
Comparative Efficacy of Antidepressants
Kasper, S. F., Fuger, J., & Möller, H. ‐. (1992) · Drugs · doi:10.2165/00003495-199200432-00004 · Cited by 137
Fluvoxamine and clomipramine in depressed patients A DOUBLE‐BLIND CLINICAL STUDY
Klok, C. J., Brouwer, G., van Praag, H. M., & Doogan, D. P. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00756.x · Cited by 137
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133
Depression: Treatment compliance in general practice
Johnson, D. A. W. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00751.x · Cited by 114
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients
Muijen, M., Roy, D. H., Silverstone, T., Mehmet, A., & Christie, M. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06353.x · Cited by 110
Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner, J. P., Gardner, E. A., Johnston, J. A., Batey, S. R., Khayrallah, M. A., Ascher, J. A., & Lineberry, C. G. (1991) · PubMed · Cited by 107
Suicide and panic disorder: a review
Noyes, R. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90077-6 · Cited by 105
Accuracy of recalled smoking data.
Krall, E. A., Valadian, I., Dwyer, J. T., & Gardner, J. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.2.200 · Cited by 97
Dl, D., Jb, C., Walshe, T., Ck, C., Feighner, J. P., Rr, F., Jp, H., Jt, H., Ed, H., & Settle, E. C. (1992) · PubMed · Cited by 87
Paroxetine in the treatment of depression ‐ a randomized comparison with amitriptyline
Laursen, A. L., Mikkelsen, P. L., Rasmussen, S., & Honoré, P. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01281.x · Cited by 83
A study comparing paroxetine placebo and imipramine in depressed patients.
Feighner, J., Cohn, J., Fabre, L., Fieve, R., Mendels, J., Shrivastava, R., & Dunbar, G. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90035-i · Cited by 82
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00005 · Cited by 80
Itil, T. M., Rk, S., Mukherjee, S., Coleman, B., & Michael, S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02134.x · Cited by 80
A Placebo-controlled Inpatient Comparison of Fluvoxamine Maleate and Imipramine in Major Depression
Feighner, J. P., Boyer, W. F., Meredith, C. H., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00006 · Cited by 79
Fluvoxamine and chlorimipramine in endogenous depression
Wilde, J. E. M. D., & Doogan, D. P. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90009-x · Cited by 77
A double‐blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients
Guillibert, E., Pélicier, Y., Archambault, J. C., Chabannes, J.-P., Cierc, G., Desvilles, M., Guibert, M., Pagot, R., Poisat, J. L., & Thobie, Y. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07192.x · Cited by 75
Fluoxetine Versus Trazodone in Depressed Geriatric Patients
Falk, W. E., Rosenbaum, J. F., Otto, M. W., Zusky, P. M., Weilburg, J. B., & Nixon, R. A. (1989) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878900200407 · Cited by 73
Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J. F. W., FREELING, P., Hallström, C., Katona, C., King, D., Leonard, B. E., Levine, S., et al. (1993) · Journal of Psychopharmacology · doi:10.1177/0269881193007001041 · Cited by 72
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner, J. P. (1985) · PubMed · Cited by 70
Fluoxetine in depressed patients: a comparison with imipramine.
Bremner, J. D. (1984) · PubMed · Cited by 69
Paroxetine in the treatment of depression: a comparison with imipramine and placebo
Feighner, J. P., & Boyer, W. F. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07190.x · Cited by 68
A double‐blind controlled clinical trial comparing fluvoxamine with imipramine.
Guelfi, J., Dreyfus, J. F., & Pichot, P. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02131.x · Cited by 67
Vestal, R. E., Thummel, K., Musser, B., & MERCER, G. D. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb01523.x · Cited by 66
A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., & Steinbook, R. M. (1985) · PubMed · Cited by 65
Treatment of major affective disorder with fluvoxamine.
Lapierre, Y. D., Browne, M., Horn, E., Lk, O., Sarantidis, D., Roberts, N., Badoe, K., & Tessier, P. (1987) · PubMed · Cited by 60
Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
de Wilde, J., Mertens, C., & Wakelin, J. S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02133.x · Cited by 59
A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression
Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58
Psychiatric care of refugees exposed to organized violence.
Jensen, S. B., Schaumburg, E., Leroy, B., Larsen, B. Ø., & Thorup, M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01313.x · Cited by 56
The course of manic-depressive illness
Ayuso-Gutiérrez, J. L., & Ramos-Brieva, J. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90013-1 · Cited by 55
A double‐blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder
Mullin, J. M., Vr, P.-G., & Whitehead, A. M. (1988) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1988.tb08510.x · Cited by 54
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients
Norton, K., Sireling, L., Bhat, A., Rao, B., & Paykel, E. S. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90051-x · Cited by 51
Amin, M. M., Ananth, J., Coleman, B. S., DARCOURT, G., Farkas, T., Goldstein, B. J., Lapierre, Y. O., Paykel, E. S., & Wakelin, J. S. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198406001-00286 · Cited by 51
A Double-Blind Comparison of Paroxetine With Imipramine in the Long-Term Treatment of Depression
Claghorn, J. L., & Feighner, J. P. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312002-00004 · Cited by 50
10. Meta‐analysis: Part 2: assessing the quality of published meta‐analyses
Wilson, A. J., & Henry, D. A. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb139704.x · Cited by 49
Lymphocyte function in major depression
Altshuler, L. L., Plaeger-Marshall, S., Richeimer, S. H., Daniels, M., & Baxter, L. R. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01314.x · Cited by 48
90068875 The antiestrogenic effect of cigarette smoking in women
Baron, J. A., Vecchia, C. L., & Levi, F. (1990) · Maturitas · doi:10.1016/0378-5122(90)90024-z · Cited by 48
Phanjoo, A. L., Wonnacott, S., & Hodgson, A. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05579.x · Cited by 48
Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients
Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P. K., Rudolf, G., Steinmeyer, E. M., Magyar, I., et al. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014346 · Cited by 47
Mk, R., Mj, A., Savla, N., Rr, S., Jm, K., & Ashford, J. J. (1991) · PubMed · Cited by 47
A Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression
Keegan, D. A., Bowen, R., Blackshaw, S. L., SALEH, S., Dayal, N., REMILLARD, F., Shrikhande, S., PEREZ, S. C., Boulton, A. L., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46
Lydiard, R. B., Laird, L. K., Morton, W. A., Steele, T. E., Kellner, C. H., Mt, L., & Jc, B. (1989) · PubMed · Cited by 46
A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients
Young, J. P. R., Coleman, A., & LADER, M. H. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.3.337 · Cited by 44
Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner, J. P., & Boyer, W. F. (1992) · PubMed · Cited by 44
The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
Rs, N., Perel, J. M., Pollock, B. G., & Dj, K. (1990) · PubMed · Cited by 44
Fluoxetine vs Amitriptyline in the Treatment of Depressed Out-patients
Laakmann, G., Blaschke, D., Engel, R. R., & Schwarz, A. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297316 · Cited by 44
March, J. S., Kobak, K. A., Jefferson, J. W., Mazza, J., & Greist, J. H. (1990) · PubMed · Cited by 44
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression
Roth, D. A., Mattes, J. A., Sheehan, K. H., & Sheehan, D. V. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90078-u · Cited by 43
A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed Outpatients
Bignamini, A., & Rapisarda, V. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00008 · Cited by 42
A double‐blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
DICK, P. H., & Ferrero, E. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02132.x · Cited by 42
Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus, J. R., Rush, A. J., Himmel, C., Tyler, D., Polatin, P. B., & Weissenburger, J. E. (1988) · PubMed · Cited by 41
Sleep and Paroxetine: A Comparison with Mianserin in Elderly Depressed Patients
DORMAN, T. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00010 · Cited by 41
A double‐blind comparison of citalopram (Lu 10–171) and amitriptyline in depressed patients
Gravem, A., Amthor, K.-F., Astrup, C., Elgen, K., GJESSING, L. R., Gunby, B., Pettersen, R., Kyrdalen, L., Vaadal, J., Øfsti, E., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02821.x · Cited by 41
A Comparative Trial of a New Antidepressant, Fluoxetine
Levine, S., Deo, R., & Mahadevan, K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.5.653 · Cited by 41
A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
Perry, P. J., Garvey, M. J., Kelly, M. W., Cook, B. L., Dunner, F. J., & Winokur, G. (1989) · PubMed · Cited by 40
A Comparison of the Antidepressant Action of Citalopram and Amitriptyline
Shaw, D., Thomas, D. R., Briscoe, M. H., Crimmins, R., Harris, B., Lovett, J., Raj, M., Lloyd, A. T., Osborne, C., Hughes, G., et al. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.4.515 · Cited by 40
Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice
Øhrberg, S., Christiansen, P. E., Severin, B., Calberg, H., Nilakantan, B., Borup, A., Søgaard, J., Larsen, S. B., Loldrup, D., Bahr, B., et al. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03294.x · Cited by 40
Fluvoxamine maleate, a serotonergic antidepressant; A comparison with chlorimipramine
Coleman, B. S., & Block, B. A. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80132-2 · Cited by 40
CORNE, S. J., & HALL, J. R. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00007 · Cited by 39
Peselow, E. D., Filippi, A.-M., Goodnick, P. J., Barouche, F., & Rr, F. (1989) · PubMed · Cited by 39
Paroxetine in the treatment of depression: A double‐blind multicenter study versus mianserin
Mertens, C., & Pintens, H. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05188.x · Cited by 39
A placebo- and imipramine-controlled study of paroxetine.
Cohn, J. B., Crowder, J. E., Wilcox, C. S., & Ryan, P. J. (1990) · PubMed · Cited by 39
Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study
Gonella, G., Baignoli, G., & Ecari, U. (1990) · Current Medical Research and Opinion · doi:10.1185/03007999009111499 · Cited by 38
Lf, F., Mb, S., & Tm, I. (1991) · PubMed · Cited by 38
A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression
de Jonghe, F. E. R. E. R., Ravelli, D. P., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014440 · Cited by 37
A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness
Perez, A., Ashford, J. J., & Biol, M. I. (1990) · Current Medical Research and Opinion · doi:10.1185/03007999009111652 · Cited by 34
Nielsen, B. M., Behnke, K., Arup, P., Christiansen, P. E., Geisler, A. E., Ipsen, E. Ø., Maach‐Møller, B., & Øhrberg, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03370.x · Cited by 32
Battegay, R., Hager, M., & Rauchfleisch, U. (2008) · Neuropsychobiology · doi:10.1159/000118159 · Cited by 32
A double‐blind study of the comparative antidepressant effect of paroxetine and amitriptyline
Kuhs, H., & Rudolf, G. A. E. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07198.x · Cited by 32
Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression
de Jonghe, F., Swinkels, J. A., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014428 · Cited by 31
Bascara, L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07196.x · Cited by 28
A double‐blind clinical trial of fluvoxamine and imipramine in patients with primary depression
Guy, W., Wilson, W. H., Ban, T. A., King, D. L., Manov, G., & Fjetland, O. K. (1984) · Drug Development Research · doi:10.1002/ddr.430040203 · Cited by 28
Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial
Noguera, R., Altuna, R., Álvarez, E., Ayuso, J. L., Casais, L., & Udina, C. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90045-t · Cited by 27
Gagiano, C. A., Muller, P. G. M., Fourie, J., & Roux, J. F. L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07191.x · Cited by 27
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.
Altamura, A. C., Percudani, M., Guercetti, G., & INVERNIZZI, G. (1989) · PubMed · Cited by 27
Fluoxetine versus clomipramine in major depressive disorders.
Ropert, R. (1989) · PubMed · Cited by 26
Judd, F. K., Moore, K., Norman, T. R., Burrows, G. D., Gupta, R. K., & Parker, G. (1993) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679309072123 · Cited by 25
Anderson, I. M., & Tomenson, B. (1994) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)90151-1 · Cited by 24
Self-citationNielsen, O. A., Morsing, I., Petersen, J. S., Larsen, T., Møller, S. E., Manniche, P. M., Skausig, O. B., Bille, N., Fredslund‐Andersen, F., Jensen, E., et al. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03136.x · Cited by 24
Benefits of new drugs are exaggerated
Owens, D. (1994) · BMJ · doi:10.1136/bmj.309.6964.1281 · Cited by 23
A Double-Blind Comparison of Paroxetine, Imipramine and Placebo in Depressed Outpatients
Feighner, J. P. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00007 · Cited by 23
Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger, W., & Haber, H. L. (1989) · PubMed · Cited by 22
Double-blind comparison of fluvoxamine and imipramine in depressed patients
Amore, M., Bellini, M., Berardi, D., Berlinzani, L., Cerviño, G., Cremonini, A., Ferrari, G. R. A., & Innamorati, A. (1989) · CINECA IRIS Institutial Research Information System (University of Genoa) · Cited by 22
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy, W., Wh, W., Ban, T. A., King, D. L., Manov, G., & Ok, F. (1984) · PubMed · Cited by 21
Meta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patients
Byrne, M. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07194.x · Cited by 20
Perspectives in Clinical Psychopharmacology of Amitriptyline and Fluvoxamine
Gasperini, M., Gatti, F., Bellini, L., Anniverno, R., & Smeraldi, E. (2008) · Neuropsychobiology · doi:10.1159/000118918 · Cited by 20
A double-blind study of fluoxetine and imipramine in major depression.
Bressa, G. M., Brugnoli, R., & Pancheri, P. (1989) · PubMed · Cited by 18
Manna, V., Martucci, N., & AGNOLI, A. (1989) · PubMed · Cited by 18
An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine
Bramanti, P., Ricci, R. M., Roncari, R., Bilone, F., Inga, F., Teti, V., Cristofaro, A. M. D., Ceccarelli, G., Perri, R. D., & Candela, L. (1988) · Current Therapeutic Research · Cited by 17
A comparative trial of a new antidepressant, fluoxetine.
Levine, S., Deo, R., & Mahadevan, K. (1989) · PubMed · Cited by 16
Tamminen, T., & Vv, L. (1989) · PubMed · Cited by 16
Loeb, C., Albano, C., & Gandolfo, C. (1989) · PubMed · Cited by 16
Fontaine, R. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90658-h · Cited by 15
Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
Ferreri, M. (1989) · PubMed · Cited by 13
Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.
Taneri, Z., & Köhler, R. (1989) · PubMed · Cited by 12
Side effects of the selective serotonin reuptake inhibitors
Garcia, C. R. L., Fialho, M. B., & Cunha, A. M. (1997) · Psiquiatría Biológica · Cited by 7
Depression: Treatment compliance in general practice
(1981) · Patient Counselling and Health Education · doi:10.1016/s0738-3991(81)80007-9 · Cited by 6
Cited by
The Journal of Mental Health Policy and Economics
(2006) · The Journal of Mental Health Policy and Economics · doi:10.1002/(issn)1099-176x · Cited by 1,243
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Self-citationMT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Liu, J., Clough, S. J., Hutchinson, A. J., Adamah-Biassi, E. B., Popovska-Gorevski, M., & Dubocovich, M. L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124742 · Cited by 630
Fava, M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 603
van der Flier, W. M., Skoog, I., Schneider, J. A., Pantoni, L., Mok, V., Chen, C. L. H., & Scheltens, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.3 · Cited by 594
Metadata
- Authors
- Anderson, I. M., & Tomenson, B. M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1995-06-03
- Volume
- 310
- Issue
- 6992
- Pages
- 1433-1438
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2048361493
- Cited by
- 306
- References
- 122
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.